Dilon Technologies Announces The Beginning Of Enrollment In Its Pivotal Trial Of The Next Generation MarginProbe™ 2 Used In Real-Time Margin Assessment - ChatMedical.ai: Global Search, Local Care | The Future of Medical Consultation


ChatMedical.AI, an innovator in AI healthcare, is a key subsidiary of UL Cell Therapeutic, a leading medical research firm based in Singapore with significant operations in North America and Asia